155 related articles for article (PubMed ID: 37169992)
1. Lipidomics and pancreatic cancer risk in two prospective studies.
Naudin S; Sampson JN; Moore SC; Albanes D; Freedman ND; Weinstein SJ; Stolzenberg-Solomon R
Eur J Epidemiol; 2023 Jul; 38(7):783-793. PubMed ID: 37169992
[TBL] [Abstract][Full Text] [Related]
2. Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case-control study within the ATBC cohort.
Barupal DK; Ramos ML; Florio AA; Wheeler WA; Weinstein SJ; Albanes D; Fiehn O; Graubard BI; Petrick JL; McGlynn KA
Int J Cancer; 2024 Feb; 154(3):454-464. PubMed ID: 37694774
[TBL] [Abstract][Full Text] [Related]
3. Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: A targeted analysis of lipidomics data in the EPIC-Potsdam cohort.
Prada M; Wittenbecher C; Eichelmann F; Wernitz A; Drouin-Chartier JP; Schulze MB
Clin Nutr; 2021 Aug; 40(8):4988-4999. PubMed ID: 34364238
[TBL] [Abstract][Full Text] [Related]
4. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
Stolzenberg-Solomon R; Derkach A; Moore S; Weinstein SJ; Albanes D; Sampson J
Gut; 2020 Nov; 69(11):2008-2015. PubMed ID: 32060129
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.
Douglas JB; Silverman DT; Weinstein SJ; Graubard BI; Pollak MN; Tao Y; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):359-69. PubMed ID: 21173171
[TBL] [Abstract][Full Text] [Related]
6. Dietary Quality and Circulating Lipidomic Profiles in 2 Cohorts of Middle-Aged and Older Male Finnish Smokers and American Populations.
Zhang T; Naudin S; Hong HG; Albanes D; Männistö S; Weinstein SJ; Moore SC; Stolzenberg-Solomon RZ
J Nutr; 2023 Aug; 153(8):2389-2400. PubMed ID: 37328109
[TBL] [Abstract][Full Text] [Related]
7. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
[TBL] [Abstract][Full Text] [Related]
8. Human serum lipidomics analysis revealed glyphosate may lead to lipid metabolism disorders and health risks.
Zhang F; Zhang Q; Liu X; Gao M; Li X; Wang Y; Chang Y; Zhang X; Huo Z; Zhang L; Shan J; Zhu B; Yao W
Environ Int; 2023 Jan; 171():107682. PubMed ID: 36495677
[TBL] [Abstract][Full Text] [Related]
9. Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort Study.
Prada M; Eichelmann F; Wittenbecher C; Kuxhaus O; Schulze MB
Diabetes Care; 2023 Apr; 46(4):836-844. PubMed ID: 36787959
[TBL] [Abstract][Full Text] [Related]
10. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipidomic markers of diet quality are associated with incident coronary heart disease in American Indian adults: the Strong Heart Family Study.
Wen X; Fretts AM; Miao G; Malloy KM; Zhang Y; Umans JG; Cole SA; Best LG; Fiehn O; Zhao J
Am J Clin Nutr; 2024 Mar; 119(3):748-755. PubMed ID: 38160800
[TBL] [Abstract][Full Text] [Related]
12. Plasma Lipidomic Profiles and Risk of Diabetes: 2 Prospective Cohorts of HIV-Infected and HIV-Uninfected Individuals.
Zhang E; Chai JC; Deik AA; Hua S; Sharma A; Schneider MF; Gustafson D; Hanna DB; Lake JE; Rubin LH; Post WS; Anastos K; Brown T; Clish CB; Kaplan RC; Qi Q
J Clin Endocrinol Metab; 2021 Mar; 106(4):999-1010. PubMed ID: 33420793
[TBL] [Abstract][Full Text] [Related]
13. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
[TBL] [Abstract][Full Text] [Related]
14. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
Stolzenberg-Solomon RZ; Newton CC; Silverman DT; Pollak M; Nogueira LM; Weinstein SJ; Albanes D; Männistö S; Jacobs EJ
Am J Epidemiol; 2015 Aug; 182(3):187-97. PubMed ID: 26085045
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal lipidomic profiles during pregnancy and associations with neonatal anthropometry: findings from a multiracial cohort.
Song Y; Lu R; Yu G; Rahman ML; Chen L; Zhu Y; Tsai MY; Fiehn O; Chen Z; Zhang C
EBioMedicine; 2023 Dec; 98():104881. PubMed ID: 38006745
[TBL] [Abstract][Full Text] [Related]
16. Prospective serum metabolomic profiling of lethal prostate cancer.
Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
[TBL] [Abstract][Full Text] [Related]
17. Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation.
Eichelmann F; Sellem L; Wittenbecher C; Jäger S; Kuxhaus O; Prada M; Cuadrat R; Jackson KG; Lovegrove JA; Schulze MB
Circulation; 2022 Jul; 146(1):21-35. PubMed ID: 35422138
[TBL] [Abstract][Full Text] [Related]
18. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.
Andreotti G; Karami S; Pfeiffer RM; Hurwitz L; Liao LM; Weinstein SJ; Albanes D; Virtamo J; Silverman DT; Rothman N; Moore LE
Epigenetics; 2014 Mar; 9(3):404-15. PubMed ID: 24316677
[TBL] [Abstract][Full Text] [Related]
19. Serum selenium and pancreatic cancer: a prospective study in the Prostate, Lung, Colorectal and Ovarian Cancer Trial cohort.
Chatterjee S; Combs GF; Chattopadhyay A; Stolzenberg-Solomon R
Cancer Causes Control; 2019 May; 30(5):457-464. PubMed ID: 30915619
[TBL] [Abstract][Full Text] [Related]
20. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study.
Stegemann C; Pechlaner R; Willeit P; Langley SR; Mangino M; Mayr U; Menni C; Moayyeri A; Santer P; Rungger G; Spector TD; Willeit J; Kiechl S; Mayr M
Circulation; 2014 May; 129(18):1821-31. PubMed ID: 24622385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
